Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Byrd-Holt DD
The burden of cirrhosis mortality by county, race, and ethnicity in the USA, 2000-19: a systematic analysis of health disparities
Research in context Evidence before this study In the USA, racial and ethnic disparities have long been apparent for cirrhosis, with cirrhosis mortality rates generally found to be higher among the American Indian or Alaska Native (AIAN) and Latino populations compared with the White population.
How Would You Manage This Patient With Type 2 Diabetes and Chronic Kidney Disease? Grand Rounds Discussion From Beth Israel Deaconess Medical Center
Get full access to this article View all available purchase options and get full access to this article. Supplemental Material References 1. Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States. Accessed at www.cdc.gov/diabetes/data/statistics-report/diagnosed-undiagnosed-diabetes.html on 22 November 2023. 2. Duru OK, Middleton T, Tewari MK, et al. The landscape of diabetic kidney disease in the United States.
Sex differences in the association of fasting glucose with HbA1c, and their consequences for mortality: A Mendelian randomization study
Summary Background Hemoglobin A1c (HbA1c) is used for diabetes diagnosis and management. HbA1c also represents iron-related erythrocyte properties which differ by sex. We investigated erythrocyte properties on HbA1c and glucose, and whether corresponding consequences for mortality differed by sex.
Association of Socioeconomic Health Care Disparities With Use of Anti-Vascular Endothelial Growth Factor and Visual Acuity Outcomes in Patients With Diabetic Macular Edema | Ophthalmic Surgery, Lasers and Imaging Retina
Clinical Science Abstract BACKGROUND AND OBJECTIVE: This study characterizes the impact of race, ethnicity, insurance status, and geographic location on anti-vascular endothelial growth factor (VEGF) use for the treatment of diabetic macular edema (DME). PATIENTS AND METHODS: This study is a retrospective cohort study.
Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association
The prevalence of diabetes has increased sharply in the United States over the past 4 decades with >34.2 million Americans with diabetes.1 More than 90% to 95% of the diabetes population are classified as type 2 diabetes (T2D).1 Type 1 diabetes, characterized by an inability to produce insulin because of autoimmunity, accounts for 5% to 10% of cases.
Racial Differences in Anti-VEGF Intravitreal Injections Among Commercially Insured Beneficiaries
BACKGROUND AND OBJECTIVE: This study assessed racial and ethnic differences in receiving anti-vascular endothelial growth factor (VEGF) intravitreal injections among commercially insured patients. PATIENTS AND METHODS: A retrospective cohort study of 104,430 patients diagnosed with wet age-related macular degeneration (AMD), diabetic retinopathy, central retinal vein occlusion (CRVO), and branch retinal vein occlusion (BRVO) in the Optum Research Database between 2011 and 2016.
Prevalence of diagnosed diabetes in American Indian and Alaska Native adults, 2006-2017
Epidemiology/Health Services Research Prevalence of diagnosed diabetes in American Indian and Alaska Native adults, 2006–2017 Ann Bullock1, http://orcid.org/0000-0001-5745-9523Karen Sheff1, Israel Hora2, Nilka Rios Burrows2, http://orcid.org/0000-0003-3455-133XStephen R Benoit2, Sharon H Saydah2, Carmen Licavoli Hardin1, Edward W Gregg3 1Division of Diabetes Treatment and Prevention, Indian Health Service, Rockville, Maryland, USA 2Division of Diabetes Translation, Centers for Disease Control...
Behavioral Counseling to Promote a Healthy Lifestyle in Persons With Cardiovascular Risk Factors: A Systematic Review for the U.S. Preventive Services Task Force | Annals of Internal Medicine
Decreases in cardiovascular mortality rates in recent decades have been attributed, in part, to improvements in modifiable risk factors (1). A substantial portion of the U.S. population has at least one modifiable risk factor for cardiovascular disease (CVD) (such as hypertension, dyslipidemia, impaired fasting glucose, the metabolic syndrome, and cigarette smoking) (2–7).
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Byrd-Holt
Contact Byrd-Holt, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack